Bora Pharmaceuticals Co., LTD. (6472.TW)

Compare

692.00

-6.00

(-0.86%)

At close: April 2 at 1:30:33 PM GMT+8

3 Dividend Stocks Offering Yields Up To 6.3%

As global markets react to easing inflation and strong earnings reports, major indices like the S&P 500 and Dow Jones have seen significant gains, while value stocks continue to outperform growth shares. In this environment of cautious optimism, dividend stocks with attractive yields can provide investors with a steady income stream amidst market volatility.

Simply Wall St. 2 months ago

6472.TW
-0.86%
EVLI.HE
Top Dividend Stocks To Consider In December 2024

As global markets navigate a period of cautious optimism marked by recent rate cuts from the Federal Reserve and political uncertainties, investors are keenly observing the broader economic landscape. Amidst this backdrop, dividend stocks present an attractive option for those seeking income stability and potential growth, especially in times of market volatility.

Simply Wall St. 3 months ago

PQ.MI

6472.TW
-0.86%
3 Reliable Dividend Stocks Yielding Up To 4.5%

As global markets show resilience with U.S. indexes approaching record highs and broad-based gains, investors are navigating a landscape marked by geopolitical tensions and economic shifts. Amidst this backdrop, dividend stocks offering reliable yields up to 4.5% can be an attractive option for those seeking steady income streams, especially when broader market volatility persists.

Simply Wall St. 4 months ago

2374.TW

6472.TW
-0.86%
Emergent BioSolutions Finalizes Sale of Baltimore-Camden Manufacturing Site to Bora Pharmaceuticals

GAITHERSBURG, Md., Aug. 20, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced it has completed the sale of its drug product facility in Baltimore-Camden to an affiliate of Bora Pharmaceuticals Co., Ltd. (“Bora”, TWSE: 6472). Emergent received approximately $30 million at closing, which is subject to customary post-closing adjustments. With the transaction closed, Bora has acquired the assets, equipment, and workforce associated with the 87,000 square foot Baltimore-

GlobeNewswire 7 months ago

EBS

6472.TW
-0.86%
Emergent BioSolutions Announces Sale of Baltimore-Camden Manufacturing Site to Bora Pharmaceuticals for $30 Million

GAITHERSBURG, Md., June 20, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that it has entered into a definitive agreement to sell its drug product facility in Baltimore-Camden to an affiliate of Bora Pharmaceuticals Co., Ltd. (“Bora”, TWSE: 6472), a leading international pharmaceutical services company, for a total value of approximately $30 million. The Camden site, which is part of Emergent’s Contract Development and Manufacturing Organization (CDMO), has clin

GlobeNewswire 9 months ago

EBS

6472.TW
-0.86%
Exploring Top Dividend Stocks In Japan For June 2024

As of June 2024, Japan's stock markets have shown mixed signals, with the Nikkei 225 experiencing slight declines while the broader TOPIX Index has gained. This divergence reflects ongoing adjustments in monetary policy and external economic influences that could impact investor sentiment towards dividend stocks. In such a market environment, selecting dividend stocks requires a focus on companies with robust fundamentals and a history of stable dividend payouts, which can offer investors...

Simply Wall St. 9 months ago

6472.TW
-0.86%

Performance Overview

Return	6472.TW	TSEC CAPITALIZATION WEIGHTED ST (^TWII)
YTD	-7.98%	-7.54%
1-Year	+1.56%	+4.06%
3-Year	+9.84%	+20.84%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Bora Pharmaceuticals Co., LTD. (6472.TW)

3 Dividend Stocks Offering Yields Up To 6.3%

Top Dividend Stocks To Consider In December 2024

3 Reliable Dividend Stocks Yielding Up To 4.5%

Emergent BioSolutions Finalizes Sale of Baltimore-Camden Manufacturing Site to Bora Pharmaceuticals

Emergent BioSolutions Announces Sale of Baltimore-Camden Manufacturing Site to Bora Pharmaceuticals for $30 Million

Exploring Top Dividend Stocks In Japan For June 2024

Performance Overview